TY - JOUR
T1 - Anti-Cancer Effects of Carnosine-A Dipeptide Molecule
AU - Prakash, Monica D.
AU - Fraser, Sarah
AU - Boer, Jennifer C.
AU - Plebanski, Magdalena
AU - de Courten, Barbora
AU - Apostolopoulos, Vasso
PY - 2021/3/2
Y1 - 2021/3/2
N2 - BACKGROUND: Carnosine is a dipeptide molecule (β-alanyl-l-histidine) with anti-inflammatory, antioxidant, anti-glycation, and chelating properties. It is used in exercise physiology as a food supplement to increase performance; however, in vitro evidence suggests that carnosine may exhibit anti-cancer properties. METHODS: In this study, we investigated the effect of carnosine on breast, ovarian, colon, and leukemic cancer cell proliferation. We further examined U937 promonocytic, human myeloid leukemia cell phenotype, gene expression, and cytokine secretion to determine if these are linked to carnosine's anti-proliferative properties. RESULTS: Carnosine (1) inhibits breast, ovarian, colon, and leukemic cancer cell proliferation; (2) upregulates expression of pro-inflammatory molecules; (3) modulates cytokine secretion; and (4) alters U937 differentiation and phenotype. CONCLUSION: These effects may have implications for a role for carnosine in anti-cancer therapy.
AB - BACKGROUND: Carnosine is a dipeptide molecule (β-alanyl-l-histidine) with anti-inflammatory, antioxidant, anti-glycation, and chelating properties. It is used in exercise physiology as a food supplement to increase performance; however, in vitro evidence suggests that carnosine may exhibit anti-cancer properties. METHODS: In this study, we investigated the effect of carnosine on breast, ovarian, colon, and leukemic cancer cell proliferation. We further examined U937 promonocytic, human myeloid leukemia cell phenotype, gene expression, and cytokine secretion to determine if these are linked to carnosine's anti-proliferative properties. RESULTS: Carnosine (1) inhibits breast, ovarian, colon, and leukemic cancer cell proliferation; (2) upregulates expression of pro-inflammatory molecules; (3) modulates cytokine secretion; and (4) alters U937 differentiation and phenotype. CONCLUSION: These effects may have implications for a role for carnosine in anti-cancer therapy.
KW - anti-cancer
KW - carnosine
KW - cytokine
KW - immunomodulation
KW - β-alanyl-l-histidine
UR - http://www.scopus.com/inward/record.url?scp=85103920074&partnerID=8YFLogxK
U2 - 10.3390/molecules26061644
DO - 10.3390/molecules26061644
M3 - Article
C2 - 33809496
AN - SCOPUS:85103920074
VL - 26
JO - Molecules
JF - Molecules
SN - 1420-3049
IS - 6
M1 - 1644
ER -